The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I dose-escalation of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) carboplatin for the frontline treatment of advanced ovarian cancer.
 
Leslie M. Randall
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen
Speakers' Bureau - AstraZeneca
Research Funding - Array BioPharma (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Mateon Therapeutics (Inst); On Target Laboratories (Inst); Pfizer (Inst); PPD (Inst)
 
Dan Gillen
No Relationships to Disclose
 
Lauren S. Krill
No Relationships to Disclose
 
Fong Wu Liu
No Relationships to Disclose
 
Krista Pfaendler
No Relationships to Disclose
 
Ramez Nassef Eskander
Honoraria - Clovis Oncology
Speakers' Bureau - AstraZeneca/MedImmune; Clovis Oncology; Genentech/Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Clovis Oncology; Genentech/Roche
 
Krishnansu Sujata Tewari
Consulting or Advisory Role - Roche/Genentech
Speakers' Bureau - AstraZeneca; Merck; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Robert Bristow
No Relationships to Disclose
 
Wen-Pin Chen
No Relationships to Disclose